International Tick Borne Disease 3rd Annual Conference


Abstracts must be submitted by Friday 13 February, 2015.  Presenting authors should state a preference for the type of presentation (oral or poster) and include contact details, institution, address, email and telephone contacts.  Original research, case presentations, clinical topics or analytical studies are acceptable presentations.

For your abstract to be considered;

  • use 12 pt Arial font only
  • use single spacing only
  • use the format-Microsoft word (.docx) file only
  • include any disclosure of interest (see below)


  • use 12 pt Arial font, BOLD CAPITALS.
  • Please make the title concise and state clearly the nature of the study.


  • List authors with principal author first and presenting author underlined.
  • Use surname followed by initials. Do not use full stops or commas between surnames and initials.
  • Omit degrees and titles
  • Include affiliations for each author. Use superscript numbering after the author’s name to indicate affiliations.


  • A maximum of 300 words (excluding title, headings and references). Note: If 300 words is exceeded, it will be sent back to be revised.
  • Specify all abbreviations in full at the first mention, followed by abbreviation in parentheses. Thereafter abbreviation only should be used.
  • You may include up to two references.
  • Do not include tables, graphs or pictures.
  • Structure with the following subheadings:
  1. Original research or analytical study
  • Background: introduction and relevance of the problem
  • Aim: a one sentence statement of the study’s specific objective or hypothesis tested
  • Methods: method used or approach taken
  • Results: a summary of data but not tables, graphs or pictures
  • Conclusion: description of main outcomes of the study
  1. Case report
  • Background: introduction and relevance of the problem
  • Reason: state why the case is of note
  • Report: should include relevant medical history, presenting problems, diagnosis and outcome
  • Reflection and recommendations: should state highlights from the report and recommendations
  1. Clinical topic
  • Background: introduction and relevance of the problem
  • Aim: state why the topic is being presented
  • Discussion: a brief outline of information to be presented
  • Conclusion: should state salient points learnt from the topic



  • Abstracts must conform to the abstract guidelines. Acceptance will depend on consistency of theme and on the quality of the abstract.
  • Oral and poster presentation authors will be informed of acceptance by Sunday 15 February, 2015.
  • There are limited oral presentations available.  Abstracts not accepted as oral presentations may alternatively be offered a poster presentation.
  • No correspondence will be entered into by the committee or conference secretariat on why individual abstracts were not accepted for an oral presentation.


Abstracts must be submitted electronically by email to by Friday 13 February, 2015.

By submitting an abstract, all authors agree to release the license to the conference organisers and give permission to publish the abstract in the conference handbook, on the website and have the poster displayed at the event, and in so doing, certify that the abstract is original work.

In addition authors giving an oral presentation, will be asked permission to have the presentation filmed and at a later date, released as part of a DVD of the conference.  We encourage acceptance of this option, but it is not mandatory. Please inform us by email if you do not wish to be included on the DVD.

NOTE: All authors will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.


All authors will be required to register for the conference by Friday 20 February, 2015. It will be assumed that any author not registered by this date has withdrawn from the program and their abstract will be removed from the handbook.


The Karl McManus Foundation recognises the considerable contribution that industry partners make to professorial and research activities.  We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in all written publications.

For an example of a disclosure of interest statement please see below;

The Apple Institute and Metabolism Corp are funded by the University of Sutcliff, USA. No pharmaceutical grants were received in the development of this study.


  • Posters will be displayed according to the poster number list published in the conference book and each display area will be identified by a number for the corresponding poster.  If you have any questions on the day please ask at the registration desk.
  • Posters will be displayed on a free standing board.  The poster dimensions should be a maximum of 750mm wide x 1000mm high (PORTRAIT). Velcro will be provided to attach posters to the boards.
  • Plastic sleeves will be provided on poster boards and we encourage you to print A4 handouts of your poster and place them in the sleeve for delegates to take.
  • Presenters are asked to be in attendance at their poster during the poster viewing session at 17.30-19.00 Saturday 7 March, 2015.  In addition authors are encouraged to be present during catering breaks where possible.
  • In preparing your poster, aim to put across a directed message in an eye-catching manner.  Please present enough data to support conclusions or to explain the points you wish to make. Data should be kept to a minimum in favour of diagrams and images.
  • All text lettering should be large enough to be legible at a distance of 1.5m. Lettering used for titles should be a minimum of 24 point (Arial or Times New Roman are recommended fonts).


PowerPoint files

Speakers are requested to email their PowerPoint presentations to by Monday 2March, 2015.  All users of Macintosh please save on Office .pptx format and arrive with plenty of time to test your presentation.  We recommend that you bring your laptop and adaptors in case you need to use it.

Speakers are also recommended to bring their presentations saved on a CD_ROM or USB memory stick.

What's On

More Whats On


Growing evidence of an emerging tick-borne disease that causes a Lyme like illness for many Australian patients

On 12 November 2015, the Senate referred the following matter to the Senate Community Affairs References Committee for inquiry and report:

The growing evidence of an emerging tick-borne disease that causes a Lyme‑like illness for many Australian patients.

Submissions should be received by 31 March 2016. The reporting date is 20 June 2016.
Nov 17, 2015

More News


Karl’s story..

Video stories..